GO:0042301 phosphate ion binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0042301 (phosphate ion binding) is a molecular function defined as binding to a phosphate ion (PO4^3-).
• Phosphate ion binding is central to nucleic acid recognition, metal-ion coordination, and drug action, as shown for MoSub1, Abeta1-40, and lanthanum carbonate [1,4,6].
• Key proteins include MoSub1, yeast inorganic pyrophosphatase, Abeta1-40, and synthetic DNA-binding complexes [1,2,4,5].
• Phosphate ion binding can be studied by NMR, isothermal titration calorimetry, and mutagenesis [1,4,8].
• Dysregulated phosphate binding contributes to renal failure, neurodegeneration, and cancer-related DNA interactions [4,5,6].
• CRISPR knockout, point mutation, knock-in, and overexpression models enable causal testing of phosphate-binding residues.
Description
Phosphate ion binding (GO:0042301) is a molecular function describing the selective interaction of a protein or chemical entity with a free phosphate ion (PO4^3-). This function is distinct from binding to phosphate esters or phosphate groups within nucleic acids, although the same structural motifs can often accommodate both. Phosphate ion binding is fundamental to enzyme catalysis, metal-ion homeostasis, and the mechanism of phosphate-binding drugs [2,6]. For researchers, GO:0042301 provides a precise annotation for proteins that directly coordinate inorganic phosphate, enabling functional comparisons across species and experimental systems [1,2]. Recent structural and biophysical studies have revealed that phosphate ion binding can modulate nucleic acid binding, protein stability, and aggregation. For example, the rice blast fungus Sub1/PC4 homolog MoSub1 binds phosphate ion and this interaction alters its ssDNA binding mode. Similarly, Abeta1-40 binds phosphate ion at its C-terminus, a finding relevant to Alzheimer's disease research. These examples illustrate why GO:0042301 is a critical term for understanding both normal physiology and disease mechanisms.
phosphate ion binding At A Glance
| GO ID | GO:0042301 |
|---|---|
| GO term | phosphate ion binding |
| Ontology | molecular_function |
| Synonym | none |
| Major function | Binding to a phosphate ion (PO4^3-) |
| Definition source | QuickGO |
| Related functions | phosphate ester binding, metal ion binding |
| Example proteins | MoSub1, yeast inorganic pyrophosphatase, Abeta1-40 |
| Research methods | NMR, ITC, mutagenesis, CRISPR models |
What Is GO:0042301?
In our own words, GO:0042301 (phosphate ion binding) is the molecular function of selectively and non-covalently interacting with a phosphate ion (PO4^3-). This activity is typically mediated by positively charged residues (e.g., arginine, lysine, histidine) or metal ions that coordinate the phosphate oxygen atoms. It is a binding function, not a catalytic activity, although it often supports catalysis or structural stabilization [2,8].
Why Is phosphate ion binding Important in Cell Biology?
Phosphate ion binding is important because inorganic phosphate is a ubiquitous cellular metabolite and signaling molecule. Proteins that bind phosphate ion participate in energy metabolism, nucleic acid metabolism, and signal transduction [2,8]. Moreover, phosphate ion binding is the mechanism of action for several therapeutic agents, such as lanthanum carbonate, which binds dietary phosphate in the gut to treat hyperphosphatemia in renal failure. In neurodegeneration, phosphate ion binding to Abeta1-40 may influence peptide aggregation and toxicity. Thus, understanding GO:0042301 helps explain both normal biology and disease interventions.
• Enables enzymes such as inorganic pyrophosphatase to coordinate phosphate substrates and products.
• Modulates nucleic acid binding by proteins like MoSub1, affecting gene regulation.
• Underlies the therapeutic action of phosphate binders used in chronic kidney disease.
• Contributes to amyloid-beta aggregation in Alzheimer's disease models.
• Guides design of metal complexes that target DNA phosphate diester backbones.
• Provides a structural basis for phosphate sensing and homeostasis.
• Facilitates development of biosensors and chelators for environmental phosphate.
• Offers a target for CRISPR-based functional studies of phosphate-binding residues.
Molecular Mechanism of phosphate ion binding
Recognition of the phosphate ion
In simple terms: The protein first grabs the phosphate ion using positive charges or metal ions.
Phosphate ion binding typically begins with electrostatic attraction between the negatively charged phosphate oxygen atoms and positively charged amino acid side chains (Arg, Lys, His) or coordinated metal ions. In yeast inorganic pyrophosphatase, divalent metal ions and inorganic phosphate analogues cooperate to form the active site. Structural mimetics of natural phosphate-binding motifs have been designed to mimic this recognition.
Conformational changes upon binding
In simple terms: Binding often changes the shape of the protein, which can alter its function.
Phosphate ion binding can induce conformational changes that modulate protein activity. For MoSub1, phosphate ion binding alters its ssDNA binding mode, suggesting a regulatory switch. Similarly, NMR studies of Abeta1-40 show that phosphate ion binds to the C-terminus and may affect peptide structure.
Coordination chemistry and metal dependence
In simple terms: Metal ions often help hold the phosphate in place.
Many phosphate-binding sites require divalent metal ions (e.g., Mg2+, Mn2+) for high-affinity binding. Cooperman et al. demonstrated that divalent metal ions, inorganic phosphate, and phosphate analogues bind to yeast inorganic pyrophosphatase, highlighting the interplay between metal and phosphate coordination. Lanthanum carbonate, a clinical phosphate binder, exploits direct lanthanum-phosphate interactions without metal-dependent enzymes.
Specificity and discrimination
In simple terms: Proteins can tell the difference between phosphate and similar molecules.
Specificity for phosphate ion over other anions is achieved through hydrogen bonding, size exclusion, and charge complementarity. Synthetic DNA-binding complexes have been shown to bind phosphate diesters, indicating that subtle differences in geometry can be exploited. Iron(oxyhydr)oxide core-shell nanoparticles also exhibit phosphate-binding specificity relevant to environmental remediation.
Regulation and competition
In simple terms: Other molecules can compete with phosphate for the same binding site.
Phosphate ion binding can be regulated by pH, ionic strength, and the presence of competing anions. In renal failure, lanthanum carbonate competes with dietary phosphate for binding in the gastrointestinal tract, reducing phosphate absorption. Metal complex-layered hydroxides have been evaluated for their interaction with phosphate ion, showing that competition with other anions affects binding efficiency.
Key Genes Involved in GO:0042301 phosphate ion binding
The following genes and proteins are experimentally linked to phosphate ion binding (GO:0042301) based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MoSub1 | Sub1/PC4 homolog in rice blast fungus; binds ssDNA and phosphate ion | Model for phosphate regulation of DNA binding |
| PPA1 (yeast) | Inorganic pyrophosphatase; hydrolyzes pyrophosphate | Classic enzyme for metal-phosphate binding studies |
| APP | Amyloid precursor protein; Abeta1-40 peptide binds phosphate ion | Alzheimer's disease research |
| ABETA1-40 | Amyloid-beta peptide; C-terminus binds phosphate ion | Neurodegeneration model |
| DNA-binding complexes | Synthetic cytotoxic complexes that bind phosphate diesters | Cancer drug design |
| Lanthanum carbonate | Phosphate-binding drug | Chronic kidney disease therapy |
| Metal complex-layered hydroxide | Inorganic material that binds phosphate ion | Phosphate removal and drug delivery |
| Phosphate-binding mimetics | Synthetic structural mimetics of natural motifs | Biomimetic chemistry |
| Iron(oxyhydr)oxide nanoparticles | Core-shell nanoparticles that bind phosphate | Environmental phosphate remediation |
| Yeast inorganic pyrophosphatase | Enzyme that binds phosphate and metal ions | Enzyme mechanism studies |
| MoSub1 variants | Mutants with altered phosphate binding | Structure-function analysis |
| Abeta1-40 fragments | Peptide fragments for NMR binding studies | Mapping phosphate interaction sites |
| Cytotoxic DNA-binding complexes | Metal complexes that target DNA | Anticancer mechanisms |
| Lanthanum-based binders | Clinical phosphate binders | Hyperphosphatemia management |
| Layered double hydroxides | Anion exchange materials | Phosphate capture |
| Phosphate-binding peptides | Short peptides designed to bind phosphate | Biosensor development |
| Metal-ion coordinated proteins | Proteins requiring metals for phosphate binding | Metalloprotein research |
How Is phosphate ion binding Regulated?
Phosphate ion binding is regulated by cellular phosphate levels, pH, and the availability of competing anions. In yeast inorganic pyrophosphatase, divalent metal ions are required for optimal phosphate binding, and their concentration modulates activity. In the rice blast fungus, MoSub1 binding to phosphate ion affects its ssDNA binding mode, suggesting that phosphate acts as a regulatory ligand. Clinically, lanthanum carbonate competes with dietary phosphate for binding, reducing phosphate absorption in renal failure patients. Additionally, synthetic metal complexes can be designed to selectively bind phosphate diesters, indicating that regulation can be engineered at the molecular level.
phosphate ion binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| APP | Alzheimer's disease | Knock-in of Abeta1-40 mutations in APP |
| Lanthanum carbonate | Hyperphosphatemia in renal failure | In vitro phosphate binding assays |
| DNA-binding complexes | Cancer | Cell lines treated with metal complexes |
| MoSub1 | Fungal pathogenesis | Knockout of MoSub1 in Magnaporthe oryzae |
| Inorganic pyrophosphatase | Metabolic disorders | Yeast knockout and point mutants |
Chronic kidney disease and hyperphosphatemia
In advanced renal failure, phosphate retention leads to hyperphosphatemia, which is treated with phosphate-binding drugs such as lanthanum carbonate. These drugs work by binding dietary phosphate in the gastrointestinal tract, preventing its absorption. This directly illustrates the therapeutic relevance of phosphate ion binding (GO:0042301).
Alzheimer's disease and neurodegeneration
Abeta1-40 binds phosphate ion at its C-terminus, as shown by heteronuclear NMR analyses. This interaction may influence peptide aggregation and toxicity, making phosphate ion binding a potential modulator of Alzheimer's disease pathology.
Cancer and DNA-targeting agents
Cytotoxic DNA-binding complexes have been shown to bind phosphate diesters, which are structurally related to phosphate ions. This binding ability is relevant to the mechanism of action of some anticancer metal complexes, suggesting that phosphate ion binding motifs can be exploited for drug design.
From phosphate ion binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of phosphate binding alter enzyme activity? | CRISPR knockout of PPA1 in yeast |
| Which residues coordinate phosphate ion? | Point mutation of Arg/Lys/His in MoSub1 |
| Can a disease-associated mutation affect phosphate binding? | Knock-in of Abeta1-40 C-terminal mutations |
| Where does phosphate binding occur in cells? | Tagged knock-in of phosphate-binding proteins with GFP |
| Does overexpression of a phosphate binder change phenotype? | Overexpression of lanthanum-binding proteins in cell lines |
| Can phosphate binding be screened at scale? | CRISPR library screening for phosphate-sensitive genes |
How to Study the phosphate ion binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| NMR | Residue-level binding sites | Mapping phosphate binding to Abeta1-40 |
| ITC | Binding affinity and thermodynamics | Characterizing metal-phosphate interactions |
| Site-directed mutagenesis | Functional importance of residues | Testing MoSub1 phosphate-binding mutants |
| Isothermal titration calorimetry | Stoichiometry of binding | Nanoparticle-phosphate binding |
| X-ray crystallography | Atomic structure of binding site | Enzyme-phosphate complexes |
| Fluorescence spectroscopy | Conformational changes | DNA-binding complex studies |
| CRISPR screening | Gene requirement for phosphate binding | Identifying novel phosphate binders |
| Bioinformatics | Sequence motifs and structural predictions | Annotating GO:0042301 proteins |
NMR spectroscopy
Heteronuclear NMR analyses have been used to map phosphate ion binding to the C-terminus of Abeta1-40. This method provides residue-level resolution of binding sites in solution.
Isothermal titration calorimetry (ITC)
ITC measures the thermodynamics of phosphate ion binding, including affinity and stoichiometry. It has been applied to study metal-phosphate interactions in enzymes and nanoparticles [2,3].
Mutagenesis and binding assays
Site-directed mutagenesis of putative phosphate-binding residues, followed by binding assays, can confirm the functional importance of specific amino acids. This approach is exemplified by studies on MoSub1 and inorganic pyrophosphatase [1,2].
Structural mimetics and chemical probes
Synthetic structural mimetics of natural phosphate-binding motifs can be used to probe binding specificity and to develop inhibitors. Metal complexes that bind phosphate diesters are also valuable chemical tools.
How CRISPR Can Be Used to Study GO:0042301 phosphate ion binding
Knockout
CRISPR knockout of genes encoding phosphate-binding proteins, such as PPA1 or MoSub1, can reveal their role in cellular phosphate homeostasis and nucleic acid metabolism [1,2]. Knockout models are essential for loss-of-function studies.
Point Mutation
Point mutations in residues predicted to coordinate phosphate ion (e.g., Arg, Lys, His) can be introduced using CRISPR base editing or homology-directed repair. Such mutants help test the contribution of individual residues to binding affinity and function [1,8].
Knock-in
Knock-in of disease-associated mutations, such as those in APP that affect Abeta1-40 phosphate binding, can model human disease in cells or animals. Tagged knock-in (e.g., GFP) allows visualization of phosphate-binding proteins in live cells.
Overexpression
Overexpression of phosphate-binding proteins or peptides can be achieved by CRISPR activation or cDNA delivery. This approach is useful for studying gain-of-function effects and for producing recombinant proteins for biochemical assays [5,6].
How EDITGENE Supports phosphate ion binding Research
Researchers studying phosphate ion binding-related genes often need to determine whether a candidate gene is causally involved in a specific biological process or disease. EDITGENE provides end-to-end CRISPR services to generate precisely engineered cell models, enabling rigorous functional validation of phosphate-binding proteins.
Contact EDITGENE today to design your custom CRISPR model for phosphate ion binding research.
Frequently Asked Questions About phosphate ion binding
What is phosphate ion binding?
Phosphate ion binding (GO:0042301) is the molecular function of selectively and non-covalently interacting with a phosphate ion (PO4^3-).
What genes are involved in phosphate ion binding?
Genes include PPA1 (yeast inorganic pyrophosphatase), MoSub1, APP (Abeta1-40), and synthetic DNA-binding complexes [1,2,4,5].
How is phosphate ion binding studied?
Common methods include NMR, ITC, mutagenesis, and CRISPR-based models [1,2,4,8].
Why is phosphate ion binding important in kidney disease?
Phosphate binders like lanthanum carbonate work by binding dietary phosphate in the gut, reducing absorption in renal failure patients.
Does phosphate ion binding play a role in Alzheimer's disease?
Yes, Abeta1-40 binds phosphate ion at its C-terminus, which may affect aggregation and toxicity.
What are the research methods for GO:0042301?
NMR, ITC, X-ray crystallography, mutagenesis, and CRISPR screening are key methods [1,2,4,5].
Can CRISPR be used to study phosphate ion binding?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable functional studies of phosphate-binding proteins.
What diseases are linked to phosphate ion binding?
Chronic kidney disease, Alzheimer's disease, and cancer are linked to phosphate ion binding [4,5,6].
What is the definition of GO:0042301?
The official definition is binding to a phosphate ion, as provided by QuickGO.
How does phosphate ion binding affect protein function?
It can induce conformational changes, modulate nucleic acid binding, and regulate enzyme activity [1,2].
Conclusion
Phosphate ion binding (GO:0042301) is a fundamental molecular function with broad implications for enzyme catalysis, nucleic acid regulation, and human disease. From yeast inorganic pyrophosphatase to Abeta1-40 and clinical phosphate binders, the ability to coordinate phosphate ion is essential for diverse biological processes [1,2,4,6]. Understanding the structural and functional basis of phosphate ion binding can inform drug design and disease modeling. CRISPR-based models offer powerful tools to dissect the causal roles of phosphate-binding proteins, and EDITGENE provides comprehensive services to accelerate this research.
References
- 1. Zhao Y et al.. 2019. The effect of phosphate ion on the ssDNA binding mode of MoSub1, a Sub1/PC4 homolog from rice blast fungus.. Proteins 87(4):257-264 PMID: 30561148
- 2. Cooperman BS et al.. 1981. Divalent metal ion, inorganic phosphate, and inorganic phosphate analogue binding to yeast inorganic pyrophosphatase.. Biochemistry 20(21):6051-60 PMID: 6118173
- 3. Spicher MT et al.. 2023. Interaction and mechanisms in the phosphate-binding of iron(oxyhydr)oxide core-shell nanoparticles.. J Colloid Interface Sci 634:418-430 PMID: 36542971
- 4. Nagata-Uchiyama M et al.. 2010. Evidence for the binding of phosphate ion to the C-terminus region in Abeta1-40 using heteronuclear NMR analyses.. Protein Pept Lett 17(2):176-80 PMID: 20214642
- 5. Simon J et al.. 2020. Proof of Phosphate Diester Binding Ability of Cytotoxic DNA-Binding Complexes.. Inorg Chem 59(19):14615-14619 PMID: 32975115
- 6. Aaseth J et al.. 2018. Lanthanum Carbonate - A New Phosphate Binding Drug in Advanced Renal Failure.. Curr Med Chem 25(1):113-117 PMID: 28486924
- 7. Ogata F. 2020. [Evaluation of Interaction between Phosphate Ion and Metal Complex-layered Hydroxide].. Yakugaku Zasshi 140(8):955-960 PMID: 32741867
- 8. Kataev EA et al.. 2015. Investigation of structural mimetics of natural phosphate ion binding motifs.. Molecules 20(2):3354-70 PMID: 25690293
